FDA Brief

Warning letters Drugs

FDA warning letter to

Sarfez Pharmaceuticals, Inc.

Issued Apr 25, 2025Posted May 20, 2025The Office of Prescription Drug Promotion (OPDP)

False & Misleading Claims/Misbranded. We haven't summarized this letter yet. Read it on fda.gov.